Adenosine Prefilled Syringes Rx
Generic Name and Formulations:
Adenosine 3mg/mL; soln for IV inj; preservative-free.
Various generic manufacturers
Indications for Adenosine Prefilled Syringes:
Paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome).
Give peripherally by rapid bolus either directly into vein or through IV line (followed by saline flush) over 1–2 seconds. Initially 6mg; if no result within 1–2 mins, may give 12mg; may repeat a second 12mg dose if needed. Max 12mg/dose.
<50kg: Give centrally or peripherally by rapid IV bolus, followed by saline flush. Initially 0.05–0.1mg/kg; if no conversion of PSVT within 1–2 mins, may give incrementally higher doses, increasing the amount by 0.05–0.1mg/kg. Continue until sinus rhythm is established, or max single dose of 0.3mg/kg is used. ≥50kg: as adult.
Sinus bradycardia. 2nd- or 3rd-degree AV block, sick sinus syndrome, unless paced.
Attempt vagal maneuvers, when clinically advisable, before administration. Discontinue if high-level heart block occurs. Avoid in asthma. Obstructive lung disease (eg, emphysema, bronchitis). Discontinue if severe respiratory difficulties occur. Elderly. Pregnancy (Cat.C).
Concomitant digoxin +/– verapamil may cause ventricular fibrillation. Potentiated by dipyridamole. Antagonized by methylxanthines (eg, caffeine, theophylline). Carbamazepine may increase degree of heart block.
Facial flushing, dyspnea, chest pressure, nausea, headache, lightheadedness, numbness, arrhythmias at time of conversion; rare: ventricular fibrillation.
Formerly known under the brand name Adenocard.
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions
- Electroacupuncture May Help Reduce Opioid Use in Chronic Musculoskeletal Pain
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- Predicting Pain Chronicization After Spine Surgery
- Chronic Low Back Pain Levels Vary Between Sex and Race
- FDA Approval of Medication With a Digital Monitoring System: Major Breakthrough or "Brave New World"?
- Errors in Clinical Notes Generated by Speech Recognition Are Not Uncommon
- Reducing Mortality After Overdose: Is Treatment for Opioid Use Disorder Effective?